Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia (STIM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00478985
Recruitment Status : Completed
First Posted : May 25, 2007
Last Update Posted : July 2, 2013
Information provided by (Responsible Party):
University Hospital, Bordeaux